Altium Capital Management LP Galera Therapeutics, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.27 - $8.28 $381,768 - $2.49 Million	-300,605 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$7.04 - $10.49 $2.12 Million - $3.15 Million	300,605 New	300,605 $2.44 Million
Q3 2021 Nov 15, 2021	SELL	$7.04 - $10.49 $1.55 Million - $2.31 Million	-219,900 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.08 - $10.44 $1.34 Million - $2.3 Million	219,900 New	219,900 $2.16 Million

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.